Holders · period archive

DNLI · Denali Therapeutics Inc.

Q2 2022 13F holders

← latest ownership dossier

Ticker: DNLI
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares